av/celldex-therapeutics--big.svg

COM:CELLDEX

Celldex

  • Stock

USD

Last Close

26.22

22/11 21:00

Market Cap

2.41B

Beta: -

Volume Today

662.65K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-81.55M
-
-118.08M
44.79%
-127.20M
7.72%
-128.53M
1.05%
-93.03M
27.62%
-151.18M
62.51%
-50.88M
66.35%
-59.78M
17.50%
-70.51M
17.95%
-112.33M
59.30%
-141.43M
25.91%
depreciation and amortization
2.94M
-
3.40M
15.48%
4.01M
17.94%
4.09M
2.02%
5.31M
29.77%
3.80M
28.42%
4.86M
27.81%
3.93M
19.12%
3.07M
21.91%
2.90M
5.61%
3.01M
3.87%
deferred income tax
-1.39M
-
90K
106.49%
350K
288.89%
1.01M
187.71%
-24.28M
2,511.32%
-765K
96.85%
671K
187.71%
-1.17M
273.92%
-227K
80.55%
-227K
0%
-22.80M
9,945.37%
stock based compensation
4.55M
-
6.85M
50.66%
12.77M
86.43%
15.32M
19.91%
12.31M
19.62%
8.08M
34.36%
4.55M
43.68%
3.92M
13.97%
8.95M
128.68%
15.61M
74.37%
23.89M
53.03%
change in working capital
7.68M
-
6.13M
20.19%
10.89M
77.66%
-6.56M
160.26%
-12.21M
86.05%
-15.37M
25.95%
-4.32M
71.88%
-299K
93.08%
-1.05M
252.51%
-3.90M
269.83%
13.46M
445.36%
accounts receivables
-445K
-
62K
113.93%
-814K
-
-96K
88.21%
-777K
709.38%
-777K
0%
-787K
1.29%
1.57M
300%
-175K
111.12%
-2.28M
1,203.43%
inventory
611K
-
-687K
-
-3.57M
419.65%
1.78M
149.94%
13.89M
678.86%
accounts payables
7.24M
-
-4.97M
-
-8.74M
75.94%
-13.11M
49.93%
-13.11M
0%
1.64M
112.49%
3.65M
123.02%
3.12M
14.51%
9.38M
200.48%
other working capital
276K
-
6.07M
2,097.83%
10.89M
79.48%
-89K
100.82%
205K
330.34%
-3.27M
1,694.15%
-4.32M
32.28%
-1.15M
73.40%
-6.28M
446.17%
-6.85M
9.00%
6.36M
192.89%
other non cash items
97K
-
72K
25.77%
288K
300%
1.64M
468.75%
11.96M
630.46%
80.20M
570.32%
-1.29M
101.61%
13.00M
1,104.48%
-1.14M
108.76%
-5.79M
408.70%
16.58M
386.42%
net cash provided by operating activities
-67.67M
-
-101.54M
50.05%
-98.89M
2.61%
-113.04M
14.31%
-99.93M
11.59%
-75.23M
24.71%
-46.41M
38.31%
-40.40M
12.95%
-60.91M
50.75%
-103.73M
70.31%
-107.29M
3.43%
investments in property plant and equipment
-4.22M
-
-1.93M
54.28%
-4.88M
152.77%
-2.75M
43.58%
-1.79M
35.01%
-813K
54.53%
-731K
10.09%
-1.55M
112.31%
-1.25M
19.52%
-1.83M
46.36%
-1.82M
0.55%
acquisitions net
4.59M
-
1.79M
61.06%
20K
-
55K
175%
27K
50.91%
69K
155.56%
purchases of investments
-112.12M
-
-148.31M
32.28%
-206.41M
39.17%
-175.73M
14.86%
-170.98M
2.70%
-171.18M
0.12%
-95.38M
44.28%
-220.32M
130.99%
-389.88M
76.96%
-188.97M
51.53%
-424.56M
124.68%
sales maturities of investments
38.89M
-
109.23M
180.85%
161.09M
47.48%
242.79M
50.72%
219.24M
9.70%
201.47M
8.10%
113.17M
43.83%
123.60M
9.21%
174.95M
41.54%
280.67M
60.43%
320.60M
14.23%
other investing activites
21K
-
-1.79M
-
342K
119.13%
net cash used for investing activites
-77.42M
-
-41.01M
47.03%
-50.19M
22.38%
68.91M
237.29%
46.47M
32.56%
29.82M
35.84%
17.08M
42.72%
-98.22M
675.05%
-216.16M
120.08%
89.94M
141.61%
-105.78M
217.61%
debt repayment
-11.03M
-
-2.96M
-
common stock issued
295.70M
-
188.84M
-
13.95M
92.61%
51.02M
265.88%
29.02M
43.12%
16.25M
44.01%
170.79M
951.16%
269.89M
58.02%
4.08M
98.49%
218.46M
5,259.62%
common stock repurchased
dividends paid
other financing activites
4.93M
-
1.17M
76.25%
4.31M
268.15%
536K
87.57%
265K
50.56%
419K
58.11%
9K
97.85%
3.40M
37,633.33%
2.48M
27.00%
net cash used provided by financing activities
289.60M
-
1.17M
99.60%
193.15M
16,394.53%
14.48M
92.50%
51.29M
254.16%
29.44M
42.60%
16.26M
44.78%
171.23M
953.24%
272.37M
59.07%
4.08M
98.50%
218.46M
5,259.62%
effect of forex changes on cash
-3K
-
-5K
66.67%
15K
400%
net change in cash
144.50M
-
-141.38M
197.84%
44.09M
131.18%
-29.65M
167.25%
-2.17M
92.67%
-15.98M
635.30%
-13.08M
18.15%
32.60M
349.30%
-4.69M
114.39%
-9.71M
106.99%
5.38M
155.44%
cash at beginning of period
24.90M
-
169.40M
580.41%
28.02M
83.46%
72.11M
157.34%
42.46M
41.11%
40.29M
5.12%
24.31M
39.66%
11.23M
53.80%
43.84M
290.28%
39.14M
10.71%
29.43M
24.82%
cash at end of period
169.40M
-
28.02M
83.46%
72.11M
157.34%
42.46M
41.11%
40.29M
5.12%
24.31M
39.66%
11.23M
53.80%
43.84M
290.28%
39.14M
10.71%
29.43M
24.82%
34.81M
18.30%
operating cash flow
-67.67M
-
-101.54M
50.05%
-98.89M
2.61%
-113.04M
14.31%
-99.93M
11.59%
-75.23M
24.71%
-46.41M
38.31%
-40.40M
12.95%
-60.91M
50.75%
-103.73M
70.31%
-107.29M
3.43%
capital expenditure
-4.22M
-
-1.93M
54.28%
-4.88M
152.77%
-2.75M
43.58%
-1.79M
35.01%
-813K
54.53%
-731K
10.09%
-1.55M
112.31%
-1.25M
19.52%
-1.83M
46.36%
-1.82M
0.55%
free cash flow
-71.89M
-
-103.47M
43.93%
-103.76M
0.29%
-115.79M
11.59%
-101.72M
12.15%
-76.05M
25.24%
-47.15M
38.00%
-41.96M
11.01%
-62.16M
48.15%
-105.56M
69.83%
-109.11M
3.36%

All numbers in USD (except ratios and percentages)